VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HRMY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HRMYHarmony Biosciences Holdings, Inc.
$38.26$2.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHRMYQuarterly Financials

Harmony Biosciences Holdings, Inc. (HRMY) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Harmony Biosciences Holdings, Inc. (HRMY) quarterly income statement — complete revenue, gross profit & net income history

HRMY Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue215.39M243.78M239.46M200.49M184.73M201.27M186.04M172.81M154.62M168.41M160.27M134.22M119.13M128.31M117.21M107.03M85.31M91.21M80.73M73.82M
Revenue Growth %16.59%21.12%28.71%16.01%19.48%19.51%16.08%28.76%29.79%31.26%36.74%25.4%39.63%40.67%45.18%44.98%42.97%62.05%77.01%94.24%
Cost of Goods Sold44.51M68.55M59.65M38.15M31.99M54.41M42.78M32.14M27.48M43.15M32.3M25.01M20.78M26.89M22.96M18.92M14.72M17.82M14.6M12.69M
COGS % of Revenue20.67%28.12%24.91%19.03%17.32%27.03%22.99%18.6%17.78%25.62%20.15%18.63%17.44%20.95%19.59%17.68%17.25%19.53%18.09%17.19%
Gross Profit170.88M175.23M179.81M162.34M152.74M146.86M143.26M140.67M127.13M125.26M127.97M109.21M98.35M101.42M94.25M88.11M70.6M73.4M66.13M61.13M
Gross Margin %79.33%71.88%75.09%80.97%82.68%72.97%77.01%81.4%82.22%74.38%79.85%81.37%82.56%79.05%80.41%82.32%82.75%80.47%81.91%82.81%
Gross Profit Growth %11.87%19.32%25.51%15.4%20.14%17.24%11.95%28.81%29.27%23.5%35.78%23.95%39.31%38.19%42.52%44.12%43.3%58.28%75.32%93.77%
Operating Expenses133.58M136.67M114.32M114.16M96.49M91.13M81.55M119.31M75.1M85.06M63.46M62.31M57.92M53.81M82.35M54.99M43.04M44.77M45.08M37.82M
OpEx % of Revenue62.02%56.07%47.74%56.94%52.23%45.28%43.84%69.04%48.57%50.51%39.6%46.42%48.62%41.94%70.26%51.38%50.45%49.08%55.83%51.23%
Selling, General & Admin64.2M86.74M59.36M64M61.95M56.47M56.16M55.73M52.91M54.76M45.96M47.34M44.63M43.72M41.8M42.32M35.46M37.31M33.34M31.32M
SG&A % of Revenue29.81%35.58%24.79%31.92%33.54%28.05%30.19%32.25%34.22%32.51%28.68%35.27%37.47%34.07%35.66%39.54%41.57%40.91%41.29%42.43%
Research & Development69.38M49.93M54.96M50.16M34.54M34.67M25.39M63.58M22.19M30.31M17.5M14.97M13.29M10.09M40.55M12.67M7.58M7.45M11.74M6.5M
R&D % of Revenue32.21%20.48%22.95%25.02%18.7%17.22%13.65%36.79%14.35%18%10.92%11.15%11.16%7.87%34.6%11.84%8.88%8.17%14.54%8.8%
Other Operating Expenses00000000000000000000
Operating Income37.29M38.56M65.49M48.18M56.24M55.73M61.71M21.36M52.03M40.2M64.51M46.9M40.42M47.61M11.9M33.12M27.56M28.63M21.05M23.31M
Operating Margin %17.31%15.82%27.35%24.03%30.45%27.69%33.17%12.36%33.65%23.87%40.25%34.95%33.93%37.11%10.15%30.94%32.3%31.39%26.08%31.58%
Operating Income Growth %-33.7%-30.81%6.12%125.6%8.09%38.64%-4.34%-54.47%28.72%-15.58%442.05%41.63%46.69%66.3%-43.47%42.06%89.61%269.05%102.82%218.95%
EBITDA43.26M45.99M71.45M54.15M62.21M61.7M67.68M27.41M58.16M46.32M70.61M52.97M46.49M53.68M17.96M39.17M32.76M33.39M25.73M28.04M
EBITDA Margin %20.08%18.87%29.84%27.01%33.68%30.65%36.38%15.86%37.61%27.5%44.06%39.46%39.02%41.84%15.33%36.6%38.39%36.61%31.86%37.99%
EBITDA Growth %-30.47%-25.46%5.58%97.56%6.97%33.19%-4.16%-48.25%25.1%-13.71%293.09%35.22%41.92%60.76%-30.17%39.69%70.49%175.03%108.35%201.1%
D&A (Non-Cash Add-back)5.97M7.43M5.97M5.97M5.97M5.97M5.97M6.05M6.12M6.13M6.11M6.06M6.06M6.07M6.06M6.05M5.2M4.76M4.67M4.73M
EBIT42.92M44.31M67.49M53.28M61.01M60.36M66.52M26.1M56.32M55.12M58.84M50.31M43.51M47.69M11.96M33.16M27.55M2.5M-5.09M23.32M
Net Interest Income2.52M2.31M2.11M1.65M1.21M268K584K301K-107K-700K-2.91M-2.78M-2.65M-3.58M-3.99M-3.93M-4.17M-4.19M-5.43M-7.23M
Interest Income5.76M5.85M5.73M5.3M5.04M4.48M4.93M4.71M4.43M4.1M4.11M3.44M3.09M0000000
Interest Expense3.23M3.55M3.62M3.65M3.84M4.21M4.35M4.4M4.54M4.8M7.01M6.22M5.73M3.58M3.99M3.93M4.17M4.19M5.43M7.23M
Other Income/Expense2.4M2.2M2M1.46M932K428K460K338K-248K-507K-12.68M-2.81M-2.64M-3.51M-3.93M-3.88M-4.17M-4.16M-31.57M-7.22M
Pretax Income39.69M40.76M67.49M49.64M57.18M56.16M62.17M21.69M51.78M39.69M51.83M44.09M37.78M44.1M7.97M29.23M23.39M24.48M-10.52M16.09M
Pretax Margin %18.43%16.72%28.18%24.76%30.95%27.9%33.42%12.55%33.49%23.57%32.34%32.85%31.71%34.37%6.8%27.31%27.41%26.83%-13.03%21.79%
Income Tax7.2M18.27M16.63M9.86M11.62M6.68M16.08M10.1M13.45M13.08M13.37M9.79M8.29M-4.41M-79.98M5.7M1.9M1.76M-902K1.97M
Effective Tax Rate %18.14%44.83%24.63%19.87%20.32%11.9%25.86%46.57%25.97%32.96%25.8%22.21%21.96%-9.99%-1003.84%19.5%8.12%7.2%8.57%12.26%
Net Income32.49M22.49M50.87M39.78M45.56M49.48M46.09M11.59M38.33M26.61M38.46M34.3M29.48M48.51M87.94M23.53M21.48M22.71M-9.62M14.12M
Net Margin %15.08%9.22%21.24%19.84%24.66%24.58%24.78%6.71%24.79%15.8%24%25.56%24.75%37.81%75.03%21.99%25.18%24.9%-11.92%19.12%
Net Income Growth %-28.69%-54.55%10.35%243.16%18.85%85.95%19.84%-66.21%30.01%-45.15%-56.27%45.77%37.24%113.56%1014.17%66.69%190.89%11020.19%-603.93%52385.19%
Net Income (Continuing)32.49M22.49M50.87M39.78M45.56M49.48M46.09M11.59M38.33M26.61M38.46M34.3M29.48M48.51M87.94M23.53M21.48M22.71M-9.62M14.12M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.550.380.870.680.780.850.790.200.670.450.630.560.480.791.440.390.350.38-0.170.24
EPS Growth %-29.49%-55.29%10.13%240%16.42%88.89%25.4%-64.29%39.58%-43.04%-56.25%43.59%37.14%107.89%947.06%62.5%169.23%--135.78%250%
EPS (Basic)0.560.390.880.690.800.870.810.200.680.460.640.570.490.821.480.400.360.39-0.170.25
Diluted Shares Outstanding58.78M58.7M58.72M58.43M58.52M58.22M58.1M57.54M57.6M58.85M60.68M60.74M61.22M61.62M61.21M60.92M60.59M60.31M57.72M58.59M
Basic Shares Outstanding57.82M57.63M58.47M57.47M57.31M57.1M56.87M56.8M56.77M58.32M59.86M59.97M59.73M59.48M59.23M59.06M58.91M58.55M57.72M56.94M
Dividend Payout Ratio---------207.69%----------